Surveillance for Respiratory Syncytial Virus (RSV) and Other Viral Respiratory Infections Among Native Americans/Alaska Natives

0
40
Federal grants application on Grants.Gov

Funding Opportunity ID:308248
Opportunity Number:RFA-IP-19-001
Opportunity Title:Surveillance for Respiratory Syncytial Virus (RSV) and Other Viral Respiratory Infections Among Native Americans/Alaska Natives
Opportunity Category:Discretionary
Opportunity Category Explanation:
Funding Instrument Type:Cooperative Agreement
Category of Funding Activity:Health
Category Explanation:
CFDA Number(s):93.185
Eligible Applicants:State governments
County governments
City or township governments
Special district governments
Independent school districts
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility:Additional Information on Eligibility: For-profit institutions are not eligible to apply.
Agency Code:HHS-CDC-HHSCDCERA
Agency Name:Department of Health and Human Services
Centers for Disease Control and Prevention – ERA
Posted Date:Oct 29, 2018
Close Date:Feb 01, 2019 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date.
Last Updated Date:Oct 29, 2018
Award Ceiling:$1,000,000
Award Floor:$750,000
Estimated Total Program Funding:$5,000,000
Expected Number of Awards:1
Description:Respiratory syncytial virus (RSV) is the leading viral cause of lower respiratory tract infection including bronchiolitis and pneumonia in infants and children worldwide. The annual rate of RSV hospitalizations for children less than 2 years of age in the US is 5.2 per 1,000, but substantially higher among Native Americans. There are currently approximately 40 vaccines or antibody products in development designed to prevent RSV infections. With potential licensure of these products on the horizon, it will be important to establish baseline estimates of the burden of RSV infections in high-risk populations, like Native Americans, and to maintain surveillance post-licensure in order to evaluate impact. Native Americans are also at higher risk for severe respiratory infections associated with human metapneumovirus (HMPV) and other viruses, which will also be monitored through this system.
Version:1





Visit the Official Webpage For More Details on Surveillance for Respiratory Syncytial Virus (RSV) and Other Viral Respiratory Infections Among Native Americans/Alaska Natives